B cell chronic lymphocytic leukemia (B-CLL) consists of the accumulation of malignant cells that apparently escape normal apoptotic regulation. We have studied the role of ␣4␤1 integrin/fibronectin interaction in preventing apoptosis of these cells in vitro. B cells from 16 patients showed constant expression of ␣4␤1 and little or no ␣5␤1. B-CLL cells cultured on fibronectin or two previously described fibronectin recombinant fragments (H89 and H0) which contain the ligands for ␣4␤1, consistently showed higher viability than control cells cultured on poly-lysine. The H89 fragment, containing the high affinity ligand CS-1, was the most efficient substrate with mean cell viability values of 72, 60 and 35% at days 2, 5 and 8 of culture, respectively. For control cells these values were 40, 27 and 15%, respectively. Parallel cell cycle analysis confirmed these results. The anti-apoptotic effect required direct contact with immobilized substrata since it was not observed when using B-CLL conditioned media alone or when clustering ␣4␤1 with specific mAbs in suspension. Quantitation of the apoptosis regulatory proteins Bcl-2 and Bax revealed that cells cultured on the H89 fragment showed high/moderate levels of Bcl-2 (with some interpatient variation) and low levels of Bax resulting in an elevated Bcl-2/Bax ratio. These results indicate that adhesion of B-CLL cells to fibronectin upregulate the Bcl-2/Bax ratio and this may contribute to the anti-apoptotic effect induced via ␣4␤1 integrin.
Introduction
B chronic lymphocytic leukemia (B-CLL) consists of the progressive accumulation of apparently mature CD5 + B cells 1, 2 which display a characteristic increased cell survival. However, these cells undergo rapid spontaneous apoptosis (programmed cell death) when cultured in vitro. 3 This fact suggests that in vivo B malignant cells are dependent on external or autocrine factors for survival. Recent studies have shown that several cytokines including interleukins (IL) 2, 4, 6, 8, 13, interferon-␣ and ␥, prevent in vitro apoptosis of B-CLL cells. [4] [5] [6] [7] [8] [9] [10] In spite of this reported protective effect, the cytokine level and composition in sera of B-CLL patients does not show major differences to those of normal individuals, suggesting that B-CLL cells in vivo must receive additional survival signals. Likely candidates to provide such signalling are cell-cell and cell-extracellular matrix (ECM) interactions mediated by adhesion receptors. These interactions are crucial for the circulation and migration of B-CLL cells, as well as other B cell malignancies, and regulate organ infiltration. 11 Previous studies have shown that B-CLL cells from different patients show a heterogeneous expression of adhesion molecules which some authors have correlated with disease stages. [12] [13] [14] Integrins are a family of adhesion receptors which have been shown to provide survival signals in many cellular sysCorrespondence: A Garcia-Pardo; Fax: 34 91 562 7518 Received 6 March 1998; accepted 21 October 1998 tems (reviewed in Ref. 15 ). For example, adhesion to the ECM component fibronectin (Fn) via ␣5␤1 integrin inhibits fibroblast apoptosis. 16 Similarly, blockade of ␣v␤3 with mAbs or ligands results in apoptosis of angiogenic blood vessels and leads to tumor regression. 17 With respect to ␣4␤1 integrin, it was shown that attachment of eosinophils to Fn induced secretion of growth factors and cell survival. 18 In another report, 19 disruption of ␣4␤1 interaction with its endothelial ligand VCAM (vascular cell adhesion molecule) with mAbs to either molecule resulted in apoptosis of germinal center B cells. For B-CLL cells it was recently shown that adhesion to stromal 20, 21 or endothelial 22 cells prevents apoptosis and in this latter case, induces expression of the IL-7 gene which may act as an autocrine survival factor. The effect of adhesion of B-CLL cells to ECM via integrins has not been studied.
The bcl-2 gene family products, such as Bcl-2 and Bax, regulate apoptosis in several cell systems including lymphocytes. 23 Bcl-2 inhibits cell death and interacts with Bax which induces apoptosis. It has been proposed that the Bcl-2/Bax ratio rather than the individual levels controls cell survival (reviewed in Ref. 24 ). B-CLL cells express high levels of Bcl-2 25, 26 which are rapidly down-regulated in in vitro cultures. Accordingly, most of the cytokines mentioned above that prevent apoptosis of B-CLL cells have been shown to upregulate Bcl-2 levels. Upregulation of Bcl-2 was also observed in the protective effect mediated by ␣5␤1 in other cell systems. 16 We have previously shown that interaction of the ␣4␤1 integrin with its ligands in the carboxy-terminal region of Fn induces intracellular signals in B cells. 27 In this report, we have studied whether adhesion to Fn via ␣4␤1 regulates apoptosis in B-CLL cells in vitro. We show that attachment to Fn or to recombinant fragments that contain the ligands for ␣4␤1 prevents spontaneous apoptosis of B-CLL cells. Furthermore, we show that this adhesion results in an elevated Bcl-2/Bax ratio which probably contributes to the survival effect.
Materials and methods

Patients
Sixteen patients (nine males and seven females, age 35-76 years) with B-CLL at 0-IV stages of the disease 28 were studied. Most of them were untreated; two had received leukeran and prednisone and one was refractory to any treatment (see Table  1 ). CD5
+ malignant B lymphocytes were purified from peripheral blood lymphocytes (PBL) by Ficoll-Hypaque (Nycomed, Oslo, Norway) and rosetting with 2-aminoethyl isothiouroniumbromide (AET)-treated sheep erythrocytes to remove T lymphocytes. After a second gradient centrifugation, the resulting B cell population was always more than 95% CD5 + as determined by flow cytometry analysis on an EPICS-CS (Coulter Científica, Mó stoles, Spain). Antibodies mAbs HP2/1 (anti-␣4 integrin subunit, epitope B1), HP1/3 (anti-␣4, epitope A) and TS2/16 (anti-␤1) were obtained from Dr F Sánchez-Madrid (Hospital de la Princesa, Madrid, Spain); mAb P4G9 (anti-␣4) has been previously described; 29 mAbs P1D6 (anti-␣5, IgG3) and P1B5 (anti-␣3, IgG1) were purchased from Calbiochem-Novabiochem (La Jolla, CA, USA); mAbs anti-CD5 and anti-CD2 were purchased from Diaclone Research (Besançon, France); mAb anti-CD19 was purchased from Immunokontact (Frankfurt, Germany); mAb sc-509 (antiBcl-2) and rabbit polyclonal anti-Bax antibody sc-526 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Immunofluorescence analyses
Cells (10 6 ) were incubated for 30 min at 4°C with 100 l of culture supernatants (1:2 dilution) or ascitis (1:100 dilution) containing the appropriate mAb. Cells were washed twice with cold PBS containing 1% BSA, and resuspended in 100 l of a 1:30 dilution of fluorescein-conjugated F(abЈ) 2 fragments of rabbit antibodies to mouse IgG (Dakopatts, Glostrup, Denmark). After 30 min at 4°C cells were washed twice, resuspended in 200 l of PBS and analyzed by flow cytometry.
Cell adhesion assays
Human plasma Fn was the generous gift of Drs B Horowitz and R Shulman (New York Blood Center, NY, USA). The recombinant Fn fragments H89 and H0 were prepared exactly as previously described. 30 Both fragments are derived from the carboxy-terminal region of Fn and contain repeats III12-15; both H89 and H0 contain the IDAPS sequence (H1 site) which is a low affinity ligand for ␣4␤1 integrin. 27 ,31 H89 also contains 89 residues from the type III connecting segment (IIICS) including the ␣4␤1 high affinity ligand CS-1 (Refs 32, 33; see Figure 1 ). A soluble recombinant form of VCAM-1 was kindly provided by Dr Roy Lobb (Biogen, Cambridge, MA, USA). Adhesion assays were performed exactly as described 27, 33 using flat-bottom high binding 96-well microtiter plates (Costar, Cambridge, MA, USA) and 10 5 cells/well. After 2 h at 37°C, attached cells were stained with 0.1% toluidine blue and the absorbance at 620 nm was determined on a Multiskan Bichromatic plate reader (Labsystems, Helsinki, Finland). Quantitation of cell attachment was done using calibration curves as described 34 and optical density at 620 nm was found to be practically a linear function of the number of cells attached in the range 5 × 10 3 to 0.3 × 10
6
. Total cellular input was calculated in these assays by spinning wells with original number of cell aliquots, then fixing, staining and measuring optical density. Inhibition with HP2/1 mAb was carried out by incubating the cells with 1:5 dilution of hybridoma supernatant for 30 min at room temperature, prior to the addition to H89-coated wells.
Cell cultures
B-CLL cells (2 × 10 6 /ml) were added to 24-or 6-well flat-bottom plates (Becton Dickinson, Meylan Cedex, France) previously coated overnight with either Fn (19 g/ml), H89 (9.5 g/ml), H0 (38 g/ml), or poly-lysine (38 g/ml, control) and cultured in RPMI 1640 medium containing 10% fetal calf serum (ICN Pharmaceuticals, Costa Mesa, CA, USA) and 40 g/ml gentamycin (GIBCO-BRL, Middlesex, UK) at 37°C and 5% CO 2 for various periods of time. Cells were removed from the wells by resuspending with a pipette. For analyses of the adherent population, non-adherent cells were carefully removed with a pipette, wells were gently washed with cold RPMI and attached cells were collected as above.
Cell incubation with soluble mAbs or ligands
Cells were incubated with appropriate mAbs (1 g/10 6 cells) or soluble H89 fragment (166 g/ml) in a total volume of 300 l in RPMI 1640-1% fetal calf serum on a rotary shaker. After 2 h at 4°C, cells were washed in cold RPMI and incubated in 300 l of a 1:50 dilution (in RPMI-1% fetal calf serum) of F(abЈ) 2 fragments of rabbit antibodies to mouse Ig (Dakopatts, Glostrup, Denmark) for an additional 2 h period. Experiments consisting of incubation with either the primary or secondary Ab alone were also included as controls. Cells were washed again, diluted to 2 × 10 6 /ml and maintained in culture in a 24-well plate (500 l/well). Analyses for cell viability (see below) were done after 1, 2 and 5 days in culture.
Cell viability
Double staining for phosphatidylserine with FITC-Annexin V (Bender MedSystems, Vienna, Austria) and for cellular DNA with propidium iodide (PI) was performed essentially as previously described. 35 Briefly, cells previously incubated with soluble reagents or removed from substrata-coated wells, were washed once with PBS and resuspended at 10 6 /ml in Hepes buffer (10 mm Hepes/NaOH pH 7.4, 150 mm NaCl, 1 mm MgCl 2 , 1.8 mm CaCl 2 , 5 mm KCl). Six microliters of FITCAnnexin V and 50 g of PI were then added, the mixture was incubated in the dark at room temperature for 10 min and analyzed by flow cytometry using two different channels. This 
Cell cycle analyses
Cells cultured under the various conditions were collected as explained and fixed with 70% ethanol in PBS for 18-20 h at 4°C, washed and resuspended in PBS at 10 6 /ml. Cells were treated with 10 g of RNase A (Sigma Chemical) for 30 min at 37°C followed by an additional 10 min incubation with 50 g/ml of PI. The cell cycle was analyzed by flow cytometry as previously described. 26 
Immunoblotting
Cells were lysed in 62 mm Tris, 10 mm dithiothreitol, 10% glycerol, 2% SDS pH 6.8, lysis buffer) and protein concentration in the lysates was determined by the BCA assay (Pierce, Rockford, IL, USA). Samples containing equal amounts of protein (20 g/lane) were separated on 12% SDS-gels and transferred to nitrocellulose membranes (Bio-Rad, Hercules, CA, USA). Filters were blocked for 2 h with 5% nonfat dry milk-3% BSA in PBS and incubated with either anti-bcl-2 or antibax antibodies overnight at 4°C. Membranes were incubated with biotinylated goat antibodies to mouse or rabbit Igs (1:1000) for 90 min, washed and incubated with peroxidasestreptavidin (1:1000; Dako, Denmark) for 45 min. Filters were washed and developed by the enhanced chemiluminiscent detection method ECL (Amersham International, Buckinghamshire, UK). Protein bands were quantitated on a computing densitometer (Molecular Dynamics, Sunnyvale, CA, USA) using the ImageQuant program.
Statistical analysis
Data from the different groups were compared using the Student's t-test for paired and impaired samples. Two-tailed statistical significances were determined. A P value of less than 0.05 was considered significant.
Results
Integrin expression on the B-CLL cells studied
The B-CLL cells used in this study were obtained from patients with the clinical characteristics shown in Table 1 . Because we were interested in the biological consequences of adhesion of these cells to extracellular matrix, we first examined their pattern of expression of relevant integrin subunits. As shown in Table 2 , all cells expressed the ␤1, ␣3 and ␣4 subunits at various levels, while expression of ␣5 was either negative or very low. Comparison of Tables 1 and 2 revealed a lack of correlation between the level of expression of ␣4 and the clinical stage of the disease. However, we could allocate two groups of patients with high and moderate/low levels of ␣4 on their B-CLL cells respectively (see Table 2 ).
Interaction of ␣4␤1 with fibronectin prevents apoptosis in B-CLL
Adhesive interactions via integrins have been shown to prevent apoptosis in several cell systems. 15 Because of the generally elevated expression of ␣4␤1 integrin on B-CLL (Table 2) we studied the effects of adhesion through this integrin on B-CLL in vitro survival. Fn, a ligand for ␣4␤1 in the extracellular matrix, or its recombinant fragments H89 and H0 were chosen as adhesion substrata (see Figure 1 ). These fragments have been shown to promote adhesion of melanoma cells 30 and are more efficient than intact Fn. As shown in Figure 1 , H89 contains two specific ligands for ␣4␤1, CS-1 and H1, while H0 contains only the H1 ligand. To determine whether B-CLL cells also attached to the H89 and H0 fragments, we performed adhesion assays using cells from two randomly chosen patients. In both cases cells attached in a dose-dependent manner and Figure 2 shows the results obtained for one of them. Quantitation of adhesion in this case rendered maximal values of 90 and 75% for attachment to the H89 and H0 fragments, respectively. These initial analyses also helped in defining suitable conditions of culture for subsequent studies.
B-CLL cells (2 × 10 6 /ml) were cultured on plates coated with either Fn, H89, H0, or the control substrate poly-lysine and their viability was measured after 2 days. In initial experi- ments, only adherent cells were studied but later analyses revealed that similar results were obtained when using the entire cell population and this therefore was used in subsequent studies. For comparison with previously defined antiapoptotic conditions induced by cytokines, cells plated on poly-lysine were also cultured in the presence of IL-4 or IL-6. Figure 3a shows the mean values from 12 cases studied. As can be observed, approximately 60% of control cells were apoptotic at this time. In contrast, the majority of cells cultured on Fn, H89 or H0 fragments remained viable with mean values of 64, 72 and 65%, respectively. Although there was heterogeneity among patients, in only one case did we not observe higher viability in cells cultured on Fn or Fn fragments. The ranges (%) of viable cells in control wells varied from 21.6 to 67.3. These ranges were 55.5-83.8 (H89), 60.1-68.7 (H0) and 42.2-82.2 (Fn). As shown in Figure 3a , these differences were statistically significant. In fact, adhesion to Fn or Fn fragments was more effective in preventing apoptosis than IL-6 (range 33.7-82) and slightly less effective than IL-4 (range 79.8-82.6) (Figure 3a) . The H89 fragment, containing the ␣4␤1 ligand CS-1, was the most efficient substrate (increase in viability being highly significant, P Ͻ 0.001) and addition of IL-6 did not increase the protective effect induced by adhesion to this fragment (range 61.2-84.1) (Figure 2a) . Subsequent experiments were therefore carried out using H89 as adhesion substrata. The protective effect of attachment to this fragment was more dramatic in some individual cases as shown in Figure 3b for patient No. 8, where 84% of cells were viable after 2 days. The anti-apoptotic effect was indeed induced via ␣4␤1 because cell pre-incubation with the function-blocking anti-␣4 mAb HP2/1, prevented cell adhesion to H89 resulting in apoptotic cell death (shown in Figure 3c for patient No. 6). Furthermore, mAb P1D6 (anti-␣5) and P1B5 (anti-␣3) had no effect on adhesion or prevention from apoptosis (not shown) thus confirming the specificity and implication of ␣4␤1.
To determine the kinetics of the protective effect induced via ␣4␤1, B-CLL cells were cultured on H89-coated plates and analyzed for viability and cell cycle after 1, 2, 5 and 8 days. As shown in Figure 4 , which represents mean values of the indicated number of cases, the percentage of cell survival decreased as the days of culture increased but it was always higher for cells attached to H89 (mean 75% ± 5.6, 72% ± 3.0, 56% ± 4.6 and 33% ± 10.8 for days 1, 2, 5 and 8, respectively) than for cells attached to poly-lysine (mean 47% ± 10, 41% ± 5.7, 27% ± 5.9 and 14% ± 7.6 for days 1, 2, 5 and 8, respectively). Viability values after 5 days of culture ranged from 6.3 to 69.4% (control) and 32.9 to 80.6% (H89). After 8 days, these values were 4.5-36.9 and 12.2-55% for control and H89, respectively. Cells also showed higher viability /ml) were cultured on wells previously coated with Fn (19 g/ml), H89 (9.5 g/ml), H0 (38 g/ml), or polylysine (38 g/ml, control). Cells were also cultured on poly-lysine in the presence of IL-4 (10 ng/ml) or IL-6 (1:100 dilution of culture supernatant). After 2 days, cell viability was determined by flow cytometry after double staining with PI and FITC-Annexin-V. Values are the mean ± s.e.m. of 12 cases. *P Ͻ 0.05; **P Ͻ 0.01; ***P Ͻ 0.001. when cultured on the H0 fragment (65% ± 2.6, 41% ± 2.6 and 25% ± 5.2 for days 2, 5 and 8, respectively; data not shown).
The above results indicated that adhesion to Fn fragments containing ligands for ␣4␤1 integrin prevented apoptosis in B-CLL cells in culture. To study if this adhesion involved the synthesis and release of soluble anti-apoptotic factors, we tested whether supernatants of cells previously incubated on the H89 fragment and displaying good viability after 2 and 5 days, were able to extend the viability of B-CLL cells cultured on poly-lysine. In experiments not shown, these supernatants did not prevent apoptosis of these cells therefore suggesting the lack or inactivity of such soluble factors.
To establish whether adhesion via ␣4␤1 was necessary for the anti-apoptotic effect or this could also be obtained by integrin engagement with soluble antibodies or ligands, B-CLL cells (three patients) were incubated in suspension with soluble H89 fragment (166 g/ml) or with P4G9 (anti-␣4), P1D6 (anti-␣5) or TS2/16 (anti-␤1) mAbs at 1 g/10 6 cells, followed by incubation with a secondary anti-mouse Ig antibody, and viability was measured after 2 and 4 days of culture. As shown in Table 3 , which represents mean values of three different cases, these soluble agents did not prevent apoptosis of B-CLL cells when compared to control cells (no reagent, irrelevant antibody P1D6, or primary or secondary Ab alone), thus indicating that adhesion to immobilised substrata was indeed necessary for delivery of the anti-apoptotic signal.
Analyses of the cell cycle were also done on cells from all 12 patients referenced in Figure 3a , and Figure 5 shows a typical example of the results consistently obtained for all cases. As shown in Figure 5 , fresh B-CLL cells (day 0) were arrested at G 0 /G 1 phase of the cell cycle, which is characteristic of quiescent living cells. Parallel to the time in culture, there was an increase on the sub-G 0 peak (representing the apoptotic population) for all conditions but this increase was far more prominent for control cells than for cells cultured on H89 or H0 fragments ( Figure 5 ). These DNA profiles were therefore consistent with the viability values obtained for cells cultured under the different conditions employed (see above and Figure 4 ).
To determine whether the anti-apoptotic effect observed after attachment to Fn fragments was also induced by the ␣4␤1 ligand VCAM-1, B-CLL cells (two patients) were cultured on VCAM-1-coated wells and analyzed for viability after various periods of time. As shown in Figure 6 , prevention from apoptosis was similar for cells attached to VCAM-1 or to the H89 fragment indicating that both ␣4␤1 ligands were equally active.
Role of Bcl-2 and Bax in the survival effect mediated by ␣4␤1 integrin
The preceding results clearly indicate that ␣4␤1-fibronectin interaction supported B-CLL cell survival. To elucidate some possible mechanisms involved in this effect, we analyzed the Effect of adhesion to VCAM-1 on survival of B-CLL cells. Cells (2 × 10 6 /ml) were cultured on wells previously coated with polylysine (38 g/ml, control) VCAM-1 (8 /ml) or H89 fragment (9.5 g/ml). At the indicated times, cell viability was determined by flow cytometry after double staining with Pl and FITC-Annexin-V. Values are the mean of two separate cases. expression of Bcl-2 and Bax, two intracellular proteins previously shown to regulate apoptosis in several cell systems. B-CLL cells cultured on poly-lysine, H89 or H0 fragments were lysed after 5 days of culture and the levels of Bcl-2 and Bax were quantitated after immunoblotting and ECL developing. Figure 7 shows two representative examples out of nine cases studied. The levels of Bcl-2 were always high in fresh B-CLL cells (day 0) when compared to normal lymphocytes, in agreement with previous reports. 24, 25 In some cases these levels remained elevated (see patient No. 10 in Figure 7 ) or decreased to moderate levels ( Figure 7 , patient No. 14) on cells attached to H89 fragment and this correlated with increased cell survival. In other cases, we did not observe a correlation between Bcl-2 expression and cell survival on H89 fragment (results not shown). In control cells Bcl-2 levels generally decreased with the time of culture (Figure 7 , patient Nos 10 and 14) and the viability was consistently low. These results indicated heterogeneity among different patients with respect to the regulation of Bcl-2 and prevented us from reaching general conclusions on the dependence of Bcl-2 levels for cell survival in vitro.
Analysis of Bax expression showed a more homogeneous pattern among patients with consistently higher levels in control cells than in H89-attached cells (shown in Figure 7 for patient Nos 10 and 14) . This suggested that a decrease in Bax levels may account for the high viability observed in cells cultured on the H89 fragment. However, we have also observed low levels of Bax in control cells with a high percentage (86.1%) of apoptosis (patient No. 10, Figure 7 and results not shown). We therefore looked at the Bcl-2/Bax ratio for both control and H89-attached cell populations. The calculated ratios for the two cases shown in Figure 7 and for three other cases are shown in Table 4 . As can be seen, an elevated Bcl-2/Bax ratio correlated with an increased survival (see patient Nos 10, 14 and 15), while a low ratio was consistent with low viability (patient Nos 12 and 16). These results suggest that an elevated Bcl-2/Bax ratio may contribute to the antiapoptotic effect induced via ␣4␤1 integrin. 37 which found consistent expression of ␤1 and heterogeneous expression of ␣4. The latter group also observed that higher levels of ␣4 corresponded to more advanced stages of B-CLL. In our study, we have also found heterogeneous expression of ␣4 and have observed two groups of B-CLL cases, with high and low levels of ␣4, respectively. We have not found a good correlation between these levels and the disease prognosis, in agreement with other reports.
14 Correlation of the stage of B-CLL and levels of ␣4 integrin (or other adhesion receptors) therefore remains a controversial issue.
Interestingly, all B-CLL studied attached very efficiently (75-90% adhesion) to Fn and the H89 and H0 fragments regardless of the levels of expression of ␣4 and on the clinical stage of the disease. Moreover, this adhesion resulted in a positive survival signal for B-CLL. The protective effect was observed not only on the adherent cell fraction but also in the entire cell population cultured on Fn or its fragments. This could be explained by the high levels of attachment observed on these substrata as well as by the fact that adhesion is a dynamic process with cells attaching and detaching during the duration of the culture. An anti-apoptotic effect mediated by ␣4␤1 integrin has been previously documented for germinal center B cells where blocking ␣4␤1-VCAM interaction with mAbs to either molecule resulted in apoptosis of these cells. 19 Interestingly, adhesion to Fn had no anti-apoptotic effect in this system and the authors attributed this to the fact that VCAM and Fn bind to different epitopes in ␣4␤1 and thus may induce different cellular effects. While the issue of the different epitopes for these two ligands is still not completely clear, a more likely explanation for their finding is the dfferent binding affinity of VCAM and Fn for ␣4␤1 30 which results in different intracellular signaling as we previously reported. 27 In the present study, however, adhesion to VCAM-1 also prevented apoptosis of B-CLL cells indicating therefore that both ␣4␤1 ligands were effective in this system.
Our results are in agreement with a recent report by Lagneaux et al, 21 which showed a role for ␣4␤1/VCAM-1 in the anti-apoptotic effect induced by interaction of B-CLL cells with bone marrow stromal cells. However, this effect also involved ␤2 integrin binding to ICAM-1 as well as other uncharacterized interactions. 21 In the present study, we have used purified Fn as well as two fragments which contain the specific binding sites for ␣4␤1 and we show for the first time that the sole interaction of ␣4␤1 with Fn or Fn carboxy-terminal fragments (or VCAM-1) reduces the onset of apoptosis in B-CLL cells. Moreover, direct contact with immobilized substrata was apparently required because: (1) ␣4␤1 clustering with specific mAbs had no effect on apoptosis; and (2) under the experimental conditions used, conditioned media from B-CLL cells cultured on H89 fragment did not prevent apoptosis of these cells when cultured on poly-lysine, in agreement with previous reports which showed that cell-cell contact was indeed essential for the effect. 21, 22 Since immobilized Fn is present in endothelium and in the ECM of lymph nodes, spleen, and other organs that B-CLL cells may infiltrate, the interactions described here likely contribute to the regulation of apoptosis of these cells in vivo.
The bcl-2 gene products Bcl-2 and Bax have been shown to play an important role in inhibiting or inducing apoptosis respectively in several systems including lymphocytes. 23 In fresh B-CLL cells, expression of Bcl-2 is generally high 25, 26 and this may explain the surveillance of these cells in vivo. Consistent with this, we have found that all cases of B-CLL analyzed for Bcl-2 expression showed high levels of this protein at the time of extraction. Upon incubation of H89 fragment these levels remained generally elevated although in some cases they decreased drastically. With respect to cell survival, we have observed good correlation in those cases in which Bcl-2 remained high or above a certain level. Below this level, cell survival was independent of Bcl-2 expression. Such heterogeneity is in accordance with previous attempts to correlate Bcl-2 levels and spontaneous apoptosis of B-CLL cells in vitro. [38] [39] [40] In contrast, in vitro protection from apoptosis by cytokines does seem to correlate with an upregulation of Bcl-2. 4, 6, 9 Since in our study we did not observe upregulation of Bcl-2, it is possible that cytokine receptors and integrins may use different signalling to produce the observed anti-apoptotic effect on B-CLL cells.
Analysis of the expression of Bax, a homolog of Bcl-2, revealed variable levels in freshly isolated cells and in general, upregulation in control samples and downregulation or stabilization in cells cultured on H89 fragment. Recent studies have suggested that the balance Bcl-2/Bax, rather than their individual levels, regulates apoptosis in B-CLL; thus, an elevated ratio of these two proteins was shown to protect B-CLL cells from anti-IgM 41 or drug-induced apoptosis. [42] [43] [44] In the present study, we have used a different approach to prevent spontaneous apoptosis and have generally observed a higher Bcl-2/Bax ratio of cells cultured on the H89 fragment than on control cells. Therefore, our findings support the notion that high Bcl-2/Bax ratios may be a common mechanism for B cells to escape apoptosis, and constitute the first report which shows that such ratios are also regulated by interaction of the ECM component Fn with ␣4␤1 integrin. Interactions with ECM and endothelium are crucial for normal lymphocyte traffic and as we show here may contribute to the accumulation of malignant cells in B-CLL patients.
